Université Lyon 1
Université de Lyon
  • Domaine : Masters du domaine SCIENCES, TECHNOLOGIES, SANTE
  • Diplôme : Master
  • Mention : Biologie moléculaire et cellulaire
  • Parcours : Leading international vaccinology education (ERASMUS+)
  • Unité d'enseignement : Immunology and Cancer
Nombre de crédits de l'UE : 3
Code APOGEE : BIO2261M
UE Obligatoire pour ce parcours
UE valable pour le semestre 3 de ce parcours
    Responsabilité de l'UE :
DELPRAT CHRISTINE
 christine.delpratuniv-lyon1.fr
04.72.68.19.54
 cdelpratfree.fr
    Contact scolarité :
BENKADOUR CHRYSTELL
 chrystell.benkadouruniv-lyon1.fr
04.72.43.29.59
    Type d'enseignement
Nb heures *
Cours Magistraux (CM)
18 h
Travaux Dirigés (TD)
0 h
Travaux Pratiques (TP)
0 h
Total du volume horaire
18 h

* Ces horaires sont donnés à titre indicatif.

    Programme - Contenu de l'UE :

Contact: Christine DELPRAT
Phone: +33 4 72 68 19 54
e-mail: christine.delprat@univ-lyon1.fr

Keywords: cancerogenesis, oncopathogens, immunoediting, immunotherapy, cancer vaccines

Aims of “Immunology & cancer”:
Using the knowledge of the students in immunology, immunopathology and infectiology, this unit is developing the concepts issued from fundamental research and leading to clinical and pharmaceutical applications in cancerology.

1.Overview of the multi-hits multi-steps and immunoediting in cancerogenesis.
2. Interactions between malignant tumors and the immune system: cancer immunogenicity, immune activation versus suppression by tumor environment
3. Mechanisms of pathogen-induced oncogenesis
4. Cancers of the immune system and consequences
5. Preventive and therapeutic anti-tumor vaccinology
6. Protection of immune-suppressed patients against secondary oncogenesis

Speakers:
Teaching Staff Immunology, oncology from University Claude Bernard Lyon 1.
Conferences concerning new research development in onco-immunology will be organized. Speakers will be invited based on their excellence. Participation of the CNRS-CRCL Associated Partner.

Learning outcomes:
How to analyse, understand and manipulate interactions between tumor cells and the immune system to overcome the cancer progression.

Updated on April 9, 2019.

    Modalités de contrôle des connaissances et Compétences 2020-2021:
TypeLibelléNatureCoef. 
CTContrôle TerminalCT : Immuno & CancerEcrit session 1 / Ecrit session 21.5
CCContrôle ContinuCC : Immuno & CancerContrôle Continu1.5
Date de la dernière mise-à-jour : 09/04/2019
SELECT * FROM parcours INNER JOIN ue_parcours ON PAR_ID_FK=PAR_ID INNER JOIN mention ON MEN_ID = PAR_MENTION_FK WHERE PAR_ACTIVATE = 0 AND UE_ID_FK='8085' ORDER BY UE_ID_FK ASC, PAR_ID_FK ASC